PharVision Advisers’s Corning GLW Stock Holding History

PharVision Advisers’s Portfolio GLW Stock Details GLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,793	Closed	-$494K	–	338
2025 Q1	$494K	Buy	10,793 +3,500	+48%	+$173K	0.69%	16
2024 Q4	$347K	Buy	+7,293	New	+$345K	0.29%	108

Other funds holding GLW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PharVision Advisers's GLW Position: Q2 2025 in Review

PharVision Advisers sold out of Corning (GLW) in Q2 2025, closing a stake of 10,793 shares — an estimated $494K sold.

PharVision Advisers first reported a position in GLW in Q4 2024 and held it in 2 quarters. The position peaked at $494K in Q1 2025. 1,537 funds tracked by Wall St. Rank hold GLW as of Q2 2025.

PharVision Advisers reported no remaining Corning position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 10,793 Corning shares in Q2 2025, an estimated $494K.
PharVision Advisers first reported a position in Corning in Q4 2024 and held it in 2 quarters.
PharVision Advisers's Corning position peaked at $494K in Q1 2025.
1,537 funds tracked by Wall St. Rank held Corning as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.